AstraZeneca PLC ADR Outperforms Market On Strong Trading Day

Dow Jones
2025/01/17

DJ AstraZeneca PLC ADR Outperforms Market On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

The AstraZeneca PLC ADR $(AZN)$ advanced 1.87% to $66.91 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.89% to 19,338.29 and Dow Jones Industrial Average falling 0.16% to 43,153.13.

This was the ADR's second consecutive day of gains.

AstraZeneca PLC ADR closed 23.68% short of its 52-week high of $87.68, which the company reached on August 30th.

The ADR demonstrated a mixed performance when compared to some of its competitors Thursday, as Eli Lilly & Co. $(LLY)$ rose 1.45% to $757.60, Biogen Inc. $(BIIB)$ rose 0.16% to $141.23, and Johnson & Johnson $(JNJ)$ rose 1.93% to $147.77.

Trading volume (3.9 M) remained 2.5 million below its 50-day average volume of 6.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled January 16, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

January 16, 2025 17:24 ET (22:24 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10